Informing and developing treatment
Personalised medicine can be applied to treatments as well as population screening; moving away from a one-size-fits-all approach where patients with the same condition were offered identical treatments. Personalised medicine aims to identify the most appropriate, targeted treatment for each individual or subsets of individuals and tailor interventions to a specific person. The ability to predict which treatments will be safe, effective and tolerated based on their particular genomic, epigenomic and proteomic profiles has the potential to both improve quality of life and reduce financial burdens on the healthcare system. However, the development of targeted medicines is challenging particularly when the target group of patients is small, or sometimes just a single patient.
The CPM explores the potential benefits and challenges of finding and developing individualised treatments for patients.
